Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

178 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Population pharmacokinetics and prediction of dopamine D2 receptor occupancy after multiple doses of RBP-7000, a new sustained-release formulation of risperidone, in schizophrenia patients on stable oral risperidone treatment.
Laffont CM, Gomeni R, Zheng B, Heidbreder C, Fudala PJ, Nasser AF. Laffont CM, et al. Among authors: gomeni r. Clin Pharmacokinet. 2014 Jun;53(6):533-43. doi: 10.1007/s40262-014-0132-7. Clin Pharmacokinet. 2014. PMID: 24464285 Clinical Trial.
Population Pharmacokinetic Modeling After Repeated Administrations of RBP-6000, a New, Subcutaneously Injectable, Long-Acting, Sustained-Release Formulation of Buprenorphine, for the Treatment of Opioid Use Disorder.
Laffont CM, Gomeni R, Heidbreder C, Jones JP 3rd, Nasser AF. Laffont CM, et al. Among authors: gomeni r. J Clin Pharmacol. 2016 Jul;56(7):806-15. doi: 10.1002/jcph.665. Epub 2016 Mar 11. J Clin Pharmacol. 2016. PMID: 26479717 Clinical Trial.
178 results